PointCross Life Sciences participated in PHUSE APAC SDE 2025, hosted by Hexaware Technologies, where industry experts convened to discuss Emerging Therapeutic Technologies, Precision Medicine, and Biomarker Data. Dr. Sapna Chandran (PointCross Life Sciences) and Mohit Sehgal, Ph.D. (Hexaware Technologies) contributed valuable insights on the role of automation, AI/ML, and regulatory-compliant data management in clinical research.
Key Insights from Our Session:
✔ Intelligent automation in biomarker data standardization and validation
✔ AI/ML-driven approaches for precision medicine
✔ The importance of high-quality clinical data in decision-making
✔ Regulatory-compliant data management to streamline submissions
We extend our appreciation to PHUSE, Hexaware Technologies, and all participants for the engaging discussions and networking opportunities.
At PointCross Life Sciences, we remain dedicated to driving innovation in clinical data management through advanced automation, AI/ML technologies, and regulatory-driven solutions.
To explore more insights from our session, view the presentation slides.